Literature DB >> 16145124

Multilocus sequence typing scheme that provides both species and strain differentiation for the Burkholderia cepacia complex.

Adam Baldwin1, Eshwar Mahenthiralingam, Kathleen M Thickett, David Honeybourne, Martin C J Maiden, John R Govan, David P Speert, John J Lipuma, Peter Vandamme, Chris G Dowson.   

Abstract

A single multilocus sequence typing (MLST) scheme was developed for precise characterization of the opportunistic pathogens of Burkholderia cepacia complex (BCC), a group composed of at least nine closely related species. Seven conserved housekeeping genes were selected after a comparison of five Burkholderia species, and a collection of strains was subjected to nucleotide sequence analysis using a nested PCR amplification approach for each gene. MLST differentiated all nine current BCC species and identified 114 sequence types within a collection of 119 strains. No differentiation was found between strains recovered from environmental or clinical sources. The improved resolution in strain identification offered by MLST was able to identify previously characterized epidemic strain lineages and also demonstrated the presence of four novel potential species groups within the complex. There was also evidence for recombination having an important role in the recent evolution of individual BCC species. This highly transferable, validated, MLST scheme provides a new means to assist in species identification as well as unambiguous strain discrimination of the BCC by a single approach. It is also the first MLST scheme designed at the outset to incorporate multiple species and should facilitate global epidemiological investigations of the BCC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145124      PMCID: PMC1234123          DOI: 10.1128/JCM.43.9.4665-4673.2005

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

1.  Diagnostically and experimentally useful panel of strains from the Burkholderia cepacia complex.

Authors:  E Mahenthiralingam; T Coenye; J W Chung; D P Speert; J R Govan; P Taylor; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

Review 2.  Burkholderia cepacia. Management issues and new insights.

Authors:  J J LiPuma
Journal:  Clin Chest Med       Date:  1998-09       Impact factor: 2.878

3.  An epidemic of burkholderia cepacia transmitted between patients with and without cystic fibrosis.

Authors:  A Holmes; R Nolan; R Taylor; R Finley; M Riley; R Z Jiang; S Steinbach; R Goldstein
Journal:  J Infect Dis       Date:  1999-05       Impact factor: 5.226

4.  Development of a multilocus sequence typing scheme for the opportunistic pathogen Pseudomonas aeruginosa.

Authors:  Barry Curran; Daniel Jonas; Hajo Grundmann; Tyrone Pitt; Christopher G Dowson
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

5.  Identification and population structure of Burkholderia stabilis sp. nov. (formerly Burkholderia cepacia genomovar IV).

Authors:  P Vandamme; E Mahenthiralingam; B Holmes; T Coenye; B Hoste; P De Vos; D Henry; D P Speert
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

6.  Invasion and intracellular survival of Burkholderia cepacia.

Authors:  D W Martin; C D Mohr
Journal:  Infect Immun       Date:  2000-01       Impact factor: 3.441

7.  Occurrence of multiple genomovars of Burkholderia cepacia in cystic fibrosis patients and proposal of Burkholderia multivorans sp. nov.

Authors:  P Vandamme; B Holmes; M Vancanneyt; T Coenye; B Hoste; R Coopman; H Revets; S Lauwers; M Gillis; K Kersters; J R Govan
Journal:  Int J Syst Bacteriol       Date:  1997-10

8.  Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by randomly amplified polymorphic DNA fingerprinting.

Authors:  E Mahenthiralingam; M E Campbell; D A Henry; D P Speert
Journal:  J Clin Microbiol       Date:  1996-12       Impact factor: 5.948

9.  Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia.

Authors:  S D Aaron; W Ferris; D A Henry; D P Speert; N E Macdonald
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

10.  A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease.

Authors:  Mark C Enright; Brian G Spratt
Journal:  Microbiology (Reading)       Date:  1998-11       Impact factor: 2.777

View more
  74 in total

1.  Antimicrobial activity of CHIR-090, an inhibitor of lipopolysaccharide biosynthesis, against the Burkholderia cepacia complex.

Authors:  Karin Bodewits; Christian R H Raetz; John R Govan; Dominic J Campopiano
Journal:  Antimicrob Agents Chemother       Date:  2010-06-01       Impact factor: 5.191

2.  Unusual distribution of Burkholderia cepacia complex species in Danish cystic fibrosis clinics may stem from restricted transmission between patients.

Authors:  Niels Nørskov-Lauritsen; Helle Krogh Johansen; Mette G Fenger; Xiaohui C Nielsen; Tacjana Pressler; Hanne V Olesen; Niels Høiby
Journal:  J Clin Microbiol       Date:  2010-06-02       Impact factor: 5.948

Review 3.  The bacterial species definition in the genomic era.

Authors:  Konstantinos T Konstantinidis; Alban Ramette; James M Tiedje
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-11-29       Impact factor: 6.237

4.  Development of a species-specific fur gene-based method for identification of the Burkholderia cepacia complex.

Authors:  Karlene H Lynch; Jonathan J Dennis
Journal:  J Clin Microbiol       Date:  2007-12-05       Impact factor: 5.948

5.  Biocide susceptibility of the Burkholderia cepacia complex.

Authors:  Helen Rose; Adam Baldwin; Christopher G Dowson; Eshwar Mahenthiralingam
Journal:  J Antimicrob Chemother       Date:  2009-01-18       Impact factor: 5.790

6.  An outbreak of Burkholderia cenocepacia bacteremia in immunocompromised oncology patients.

Authors:  T Mann; D Ben-David; A Zlotkin; D Shachar; N Keller; A Toren; A Nagler; G Smollan; A Barzilai; G Rahav
Journal:  Infection       Date:  2010-04-01       Impact factor: 3.553

7.  SNaPBceBcon: a Practical Tool for Identification and Genotyping of Burkholderia cepacia and Burkholderia contaminans.

Authors:  Ricardo Araujo; Rita Caramalho; Carla Coutinho; Isabel Sá-Correia
Journal:  J Clin Microbiol       Date:  2015-12-09       Impact factor: 5.948

8.  Direct culture-independent Strain typing of Burkholderia cepacia complex in sputum samples from patients with cystic fibrosis.

Authors:  Pavel Drevinek; Sarka Vosahlikova; Klara Dedeckova; Ondrej Cinek; Eshwar Mahenthiralingam
Journal:  J Clin Microbiol       Date:  2010-02-24       Impact factor: 5.948

9.  Key role for efflux in the preservative susceptibility and adaptive resistance of Burkholderia cepacia complex bacteria.

Authors:  Laura Rushton; Andrea Sass; Adam Baldwin; Christopher G Dowson; Denise Donoghue; Eshwar Mahenthiralingam
Journal:  Antimicrob Agents Chemother       Date:  2013-04-15       Impact factor: 5.191

10.  Identification and onion pathogenicity of Burkholderia cepacia complex isolates from the onion rhizosphere and onion field soil.

Authors:  Janette L Jacobs; Anthony C Fasi; Alban Ramette; James J Smith; Raymond Hammerschmidt; George W Sundin
Journal:  Appl Environ Microbiol       Date:  2008-03-14       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.